- Home
- COCH vs XGN Comparison
COCH vs XGN Comparison
Compare COCH & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- XGN
- Stock Information
- Founded
- COCH 1995
- XGN 2002
- Country
- COCH United States
- XGN United States
- Employees
- COCH N/A
- XGN N/A
- Industry
- COCH Blank Checks
- XGN Medical Specialities
- Sector
- COCH Finance
- XGN Health Care
- Exchange
- COCH Nasdaq
- XGN Nasdaq
- Market Cap
- COCH 64.4M
- XGN 72.3M
- IPO Year
- COCH N/A
- XGN 2019
- Fundamental
- Price
- COCH $1.84
- XGN $5.52
- Analyst Decision
- COCH Strong Buy
- XGN Buy
- Analyst Count
- COCH 4
- XGN 1
- Target Price
- COCH $8.00
- XGN $7.00
- AVG Volume (30 Days)
- COCH 42.8K
- XGN 193.9K
- Earning Date
- COCH 11-14-2024
- XGN 11-12-2024
- Dividend Yield
- COCH N/A
- XGN N/A
- EPS Growth
- COCH N/A
- XGN N/A
- EPS
- COCH N/A
- XGN N/A
- Revenue
- COCH $278,000.00
- XGN $55,751,000.00
- Revenue This Year
- COCH N/A
- XGN $6.74
- Revenue Next Year
- COCH $17.09
- XGN $17.32
- P/E Ratio
- COCH N/A
- XGN N/A
- Revenue Growth
- COCH 15.35
- XGN 8.00
- 52 Week Low
- COCH $1.08
- XGN $1.30
- 52 Week High
- COCH $11.46
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- COCH 38.78
- XGN 67.57
- Support Level
- COCH $1.64
- XGN $4.42
- Resistance Level
- COCH $2.06
- XGN $6.22
- Average True Range (ATR)
- COCH 0.20
- XGN 0.51
- MACD
- COCH -0.02
- XGN 0.10
- Stochastic Oscillator
- COCH 38.24
- XGN 72.00
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.